T5	Subject 9 23	Three patients
T7	Effect 38 82	symptoms of inflammatory bowel disease (IBD)
T8	Treatment 90 108	rofecoxib exposure
T9	Population 9 14	Three
T10	Drug 90 99	rofecoxib
T11	Route 100 108	exposure
T6	Adverse_event 28 37	developed
E1	Adverse_event:T6